|By PR Newswire||
|September 4, 2014 01:29 PM EDT||
PARSIPPANY, N.J., Sept. 4, 2014 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare applauds CVS for its courageous decision to end the sale of tobacco products. This monumental step will go a long way towards improving and protecting public health.
Banning the sale of cigarettes and other harmful tobacco products from its shelf will help CVS encourage current smokers to quit, may prevent potential smokers from starting the deadly habit and may ultimately reduce the prevalence of cigarette smoking, which causes 480,000 deaths annually. CVS has GSK's full support in its quit-smoking initiatives and shares its philosophy of saying "no" to cigarettes and "yes" to quitting.
As leaders in smoking cessation, GSK encourages all smokers who are emboldened by CVS' decision to look to Nicorette gum and NicoDerm CQ patch to help them begin their quit journey. Nicorette and NicoDerm CQ can double a smoker's chances of quitting versus placebo when used as directed. We are committed to helping every smoker achieve a smoke-free life.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its well-known brands include Nicorette® and NicoDerm® CQ, the leading smoking cessation products; alli, the only FDA-OTC weight loss aid; as well as medicine cabinet staples, Aquafresh,® Sensodyne,® Tums® and Breathe Right,® all of which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.
GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.GSK.com.
GSK Consumer Healthcare
SOURCE GlaxoSmithKline Consumer Healthcare
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
Jan. 19, 2017 08:45 PM EST Reads: 5,250
Jan. 19, 2017 07:30 PM EST Reads: 4,231
Jan. 19, 2017 06:30 PM EST Reads: 6,317
Jan. 19, 2017 05:30 PM EST Reads: 3,630
Jan. 19, 2017 05:15 PM EST Reads: 3,107
Jan. 19, 2017 05:15 PM EST Reads: 1,311
Jan. 19, 2017 04:45 PM EST Reads: 3,757
Jan. 19, 2017 04:45 PM EST Reads: 3,478
Jan. 19, 2017 04:15 PM EST Reads: 5,408
Jan. 19, 2017 04:00 PM EST Reads: 5,434
Jan. 19, 2017 03:45 PM EST Reads: 1,796
Jan. 19, 2017 03:30 PM EST Reads: 1,040
Jan. 19, 2017 02:15 PM EST Reads: 1,063
Jan. 19, 2017 02:00 PM EST Reads: 4,788
"There's a growing demand from users for things to be faster. When you think about all the transactions or interactions users will have with your product and everything that is between those transactions and interactions - what drives us at Catchpoint Systems is the idea to measure that and to analyze it," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York Ci...
Jan. 19, 2017 01:15 PM EST Reads: 5,681